By removing BTLA-mediated suppression, elevated T cell activation may lead to off-target tissue damage, particularly in organs susceptible to autoimmunity such as the skin, gut, liver, lungs, and endocrine glands [104,105]. This evidence concerns the gene BTLA and Autoimmunity.